E. Klein

4.0k total citations
19 papers, 1.5k citations indexed

About

E. Klein is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, E. Klein has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 3 papers in Cognitive Neuroscience. Recurrent topics in E. Klein's work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). E. Klein is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). E. Klein collaborates with scholars based in United States, Germany and Austria. E. Klein's co-authors include Cheuk Y. Tang, Julio Rosenstock, Joseph C. Wu, Lawrence Blonde, David M. Kendall, Carlos A. Aguilar‐Salinas, Kristin Taylor, J. Han, Susanna Mac and Michael Trautmann and has published in prestigious journals such as Annals of Internal Medicine, American Journal of Psychiatry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

E. Klein

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Klein United States 12 868 368 348 314 250 19 1.5k
Per Grybäck Sweden 19 500 0.6× 532 1.4× 161 0.5× 108 0.3× 138 0.6× 43 1.7k
Carolyn Watson United States 24 208 0.2× 166 0.5× 281 0.8× 192 0.6× 791 3.2× 39 2.7k
David Surridge Canada 22 581 0.7× 83 0.2× 142 0.4× 118 0.4× 83 0.3× 32 1.5k
Antonella Napolitano United Kingdom 18 325 0.4× 167 0.5× 321 0.9× 45 0.1× 157 0.6× 29 1.3k
William J. Raum United States 20 480 0.6× 175 0.5× 202 0.6× 27 0.1× 115 0.5× 42 1.5k
Victoria Salem United Kingdom 17 597 0.7× 384 1.0× 391 1.1× 48 0.2× 317 1.3× 54 1.9k
Michael G. Wyllie United Kingdom 26 570 0.7× 277 0.8× 478 1.4× 33 0.1× 185 0.7× 126 2.2k
Dorie W. Schwertz United States 24 180 0.2× 99 0.3× 475 1.4× 33 0.1× 70 0.3× 59 1.8k
Nikolas Klein Austria 17 74 0.1× 159 0.4× 165 0.5× 118 0.4× 443 1.8× 21 1.2k
Marta Baviera Italy 20 254 0.3× 73 0.2× 212 0.6× 185 0.6× 90 0.4× 45 1.1k

Countries citing papers authored by E. Klein

Since Specialization
Citations

This map shows the geographic impact of E. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Klein more than expected).

Fields of papers citing papers by E. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Klein. The network helps show where E. Klein may publish in the future.

Co-authorship network of co-authors of E. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of E. Klein. A scholar is included among the top collaborators of E. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Klein. E. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Desouza, Cyrus, Richard Holcomb, Julio Rosenstock, et al.. (2019). Results of a Study Comparing Glycated Albumin to Other Glycemic Indices. The Journal of Clinical Endocrinology & Metabolism. 105(3). 677–687. 25 indexed citations
2.
Henry, Robert R., E. Klein, Jenny Han, & Nayyar Iqbal. (2016). Efficacy and Tolerability of Exenatide Once Weekly Over 6 Years in Patients with Type 2 Diabetes: An Uncontrolled Open-Label Extension of the DURATION-1 Study. Diabetes Technology & Therapeutics. 18(11). 677–686. 40 indexed citations
3.
Frías, Juan P., Samer Nakhle, James A. Ruggles, et al.. (2016). Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐controlled trial. Diabetes Obesity and Metabolism. 19(1). 40–48. 23 indexed citations
4.
Shah, Sukrut, Anne Hermanowski‐Vosatka, D. Plotkin, et al.. (2011). Effects of an 11 β ‐hydroxysteroid dehydrogenase type 1 inhibitor, MK‐0916, in patients with type 2 diabetes mellitus and metabolic syndrome. Diabetes Obesity and Metabolism. 13(6). 498–504. 132 indexed citations
5.
Liebl, Andreas, Roel P.L.M. Hoogma, Éric Renard, et al.. (2009). A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obesity and Metabolism. 11(11). 1001–1008. 53 indexed citations
6.
Rosenstock, Julio, et al.. (2009). Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Current Medical Research and Opinion. 25(10). 2401–2411. 251 indexed citations
7.
Childs, Belinda P., et al.. (2007). Considering Pramlintide Therapy for Postprandial Blood Glucose Control. Diabetes Spectrum. 20(2). 108–114. 2 indexed citations
8.
Blonde, Lawrence, E. Klein, J. Han, et al.. (2006). Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. Diabetes Obesity and Metabolism. 8(4). 436–447. 357 indexed citations
9.
Garber, A. J., E. Klein, Simon Bruce, Serap Sankoh, & Pharis Mohideen. (2005). Metformin‐glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy. Diabetes Obesity and Metabolism. 8(2). 156–163. 62 indexed citations
10.
Klein, E., et al.. (2000). A REVIEW OF CRITERIA FUNCTIONS AND RESPONSE SURFACE METHODOLOGY FOR THE OPTIMIZATION OF ANALYTICAL SCALE HPLC SEPARATIONS. Journal of Liquid Chromatography & Related Technologies. 23(14). 2097–2121. 45 indexed citations
11.
Klein, E., et al.. (2000). Optimization of Ion-Exchange Protein Separations Using a Vector Quantizing Neural Network. Biotechnology Progress. 16(3). 506–512. 8 indexed citations
12.
Wu, Joseph C., Monte S. Buchsbaum, J. Christian Gillin, et al.. (1999). Prediction of Antidepressant Effects of Sleep Deprivation by Metabolic Rates in the Ventral Anterior Cingulate and Medial Prefrontal Cortex. American Journal of Psychiatry. 156(8). 1149–1158. 250 indexed citations
13.
Klein, E., et al.. (1997). Automatic classification of chromatographic peaks. 3262–3266 vol.5. 1 indexed citations
14.
Wu, Joseph C., Gerald A. Maguire, Glyndon D. Riley, et al.. (1995). A positron emission tomography [18F]deoxyglucose study of developmental stuttering. Neuroreport. 6(3). 501–505. 140 indexed citations
15.
Klein, E., A Hefez, & Peretz Lavie. (1984). Effects of Clomipramine Infusion on Sleep in Depressed Patients. Neuropsychobiology. 11(2). 85–88. 9 indexed citations
16.
Klein, E., et al.. (1977). Anorectal Gonococcal Infection. Annals of Internal Medicine. 86(3). 340–346. 69 indexed citations
17.
Klein, E.. (1977). Therapeutic Regimens for Anorectal Gonococcal Infection in Males. Archives of Internal Medicine. 137(9). 1234–1234. 3 indexed citations
18.
Reinwein, D. & E. Klein. (1962). [The effect of inorganic blood iodine on the iodine level in nontoxic goiter].. PubMed. 39. 328–37. 3 indexed citations
19.
Reinwein, D. & E. Klein. (1960). DER EINFLUSS DES ANORGANISCHEN BLUTJODES AUF DEN JODUMSATZ DER MENSCHLICHEN SCHILDDRÜSE. European Journal of Endocrinology. XXXV(IV). 485–494. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per Grybäck Breakdown of academic impact, for papers by Carolyn Watson Breakdown of academic impact, for papers by David Surridge Breakdown of academic impact, for papers by Antonella Napolitano Breakdown of academic impact, for papers by William J. Raum Breakdown of academic impact, for papers by Victoria Salem Breakdown of academic impact, for papers by Michael G. Wyllie Breakdown of academic impact, for papers by Dorie W. Schwertz Breakdown of academic impact, for papers by Nikolas Klein Breakdown of academic impact, for papers by Marta Baviera
Rankless by CCL
2026